Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The convergence of genetic engineering and artificial intelligence brings both the potential to revolutionize medicine and ...

The convergence of genetic engineering and artificial intelligence brings both the potential to revolutionize medicine and ...

Three new observational studies on influenza and COVID-19 vaccine uptake find that more than a third of US adults say they ...

Exposure to air pollution has previously been tied to a variety of adverse health effects, among them increased risk of ...

Argentina dCenter of Excellence in Respiratory Pathogens, Hospices Civils de Lyon and Centre International de Recherche en ...

Respiratory virus data included in the interactive data application is up-to-date as of September 14, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.

Additionally, exploration of HBV integration hotspots reveals obvious hotspot areas of HBV integration on the human genome. Virus integration in these hotspot areas is often associated with the ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

You will be able to get a free RSV vaccination because you’re aged 75 to 79 years (or recently turned 80). Every year, thousands of people in your age group need hospital care for RSV infection. RSV ...

Respiratory virus season is right around the corner. Although rates are still nowhere close to where they were during 2022’s omicron wave, percent positivity remains high and was higher in late ...